All News #Library
Biotech
AnBogen Therapeutics Unveils ABT-301 Breakthroughs at AACR 2026
13 Apr 2026 //
PR NEWSWIRE
FDA clears Anbogen to start Phase 1/2 trial of ABT-301
04 Aug 2025 //
PR NEWSWIRE
Anbogen Inks Deal With BeiGene For Colorectal Cancer Therapy
27 Sep 2024 //
BIOSPECTRUM ASIA

Market Place
Sourcing Support